Issuer directory · Pharmaceuticals

Pharmaceuticals: private offerings on SEC Form D.

184 issuers in this group filed a Form D since 2024, reported at least $1 million sold, and either raised from ten or more investors or amended the notice at least once. Ranked by the amount reported sold on the newest notice, 100 to a page. The platform column names the AltStreet-reviewed platform an issuer belongs to; "direct" means none is on record.

IssuerReported soldInvestorsExemptionNewest noticeFilingsPlatform
Par Health, Inc.$763.0M234506(c)Nov 25, 20251direct
BICYCLE THERAPEUTICS PLC$555.5M19506(b)Jun 12, 20241direct
Immunovant, Inc.$450.0M11506(b)Jan 21, 20251direct
TrialSpark, Inc.$372.2M16506(b)Jul 2, 20241direct
DBV Technologies S.A.$306.9M14506(b)Apr 17, 20251direct
Paragon Biosciences Emalex Capital, Inc.$270.0M42506(b)Jul 8, 20254direct
Olema Pharmaceuticals, Inc.$250.0M26506(b)Dec 12, 20241direct
MAPS Public Benefit Corp$215.1M62506(b)Sep 29, 20231direct
Endo, Inc.$170.6M404506(b)May 6, 20242direct
TORL Biotherapeutics LLC$158.3M52506(b)Apr 17, 20241direct
Triana Biomedicines, Inc.$120.1M20506(b)Dec 4, 20251direct
Pelage Pharmaceuticals, Inc.$120.0M5506(b)Nov 24, 20251direct
Reunion Neuroscience, Inc.$119.8M9506(b)Sep 9, 20254direct
Renibus Therapeutics, Inc.$110.9M59506(b)Jul 17, 20253direct
LB PHARMACEUTICALS INC$110.7M6506(b)Jan 10, 20242direct
KORTUC USA INC.$108.7M14506(b)May 16, 20231direct
Quoin Pharmaceuticals, Ltd.$105.3M27506(b)Oct 23, 20251direct
Context Therapeutics Inc.$100.0M26506(b)May 16, 20241direct
TENAX THERAPEUTICS, INC.$99.7M24506(b)Aug 23, 20241direct
Enliven Therapeutics, Inc.$90.0M20506(b)Apr 3, 20241direct
BlossomHill Therapeutics, Inc.$88.6M44506(b)Jan 2, 20241direct
Enlaza Therapeutics, Inc.$84.0M16506(b)Aug 9, 20241direct
ALIMERA SCIENCES INC$81.0M16506(b)May 31, 20232direct
Tango Therapeutics, Inc.$80.0M17506(b)Aug 24, 20231direct
Aclaris Therapeutics, Inc.$80.0M19506(b)Dec 4, 20241direct
LEAP THERAPEUTICS, INC.$77.2M121506(b)Mar 13, 20231direct
Avilar Therapeutics, Inc.$75.3M5506(b)Feb 13, 20232direct
Mind Medicine (MindMed) Inc.$75.0M2506(b)Mar 18, 20241direct
Altesa BioSciences, Inc.$75.0M17506(b)Feb 23, 20261direct
Ratio Therapeutics, Inc.$70.0M57506(b)Jul 31, 20261direct
Rivus Pharmaceuticals, Inc.$66.0M7506(b)Sep 17, 20241direct
OnKure Therapeutics, Inc.$65.0M20506(b)Oct 21, 20241direct
Sparrow Pharmaceuticals, Inc.$61.8M17506(b)Jul 1, 20251direct
BiomX Inc.$61.5M34506(b)Apr 1, 20241direct
Arthrosi Therapeutics, Inc.$60.9M13506(b)Jun 24, 20251direct
Gilgamesh Pharma Inc.$60.0M40506(b)Mar 24, 20261direct
QurAlis Corp$60.0M27506(b)Mar 13, 20231direct
Corner Therapeutics, Inc.$58.5M14506(b)Aug 11, 20253direct
Arizona Isotopes Science Research Corp.$58.3M105506(b)May 29, 20245direct
Alveus Therapeutics, Inc.$56.9M17506(b)Jan 14, 20261direct
LEXICON PHARMACEUTICALS, INC.$55.7M1506(b)Feb 17, 20261direct
Aeovian Pharmaceuticals, Inc.$55.0M13506(b)Dec 22, 20251direct
Lomond Therapeutics Holdings, Inc.$53.9M28506(b)Feb 11, 20252direct
OnKure, Inc.$53.8M15506(b)Apr 3, 20231direct
vTv Therapeutics Inc.$51.0M4506(b)Mar 7, 20241direct
Pelthos Therapeutics Inc.$50.1M13506(b)Jul 10, 20251direct
Verrica Pharmaceuticals Inc.$50.0M21506(b)Dec 10, 20251direct
HYPERION DEFI, INC.$50.0M5506(b)Jul 22, 20251direct
Osteal Therapeutics, Inc.$50.0M16506(b)Jun 6, 20241direct
Ikena Oncology, Inc.$42.6M48506(b)Aug 18, 20231direct
Curevo, Inc.$42.4M11506(b)Mar 18, 20251direct
Melt Pharmaceuticals, Inc.$42.3M309506(b)Apr 8, 20249direct
Jaguar Health, Inc.$40.8M1506(b)Jul 1, 20261direct
AN2 Therapeutics, Inc.$40.0M16506(b)Mar 25, 20261direct
Revalesio Corp$38.9M31506(b)Dec 16, 20253direct
Comanche Biopharma Corp.$37.5M7506(b)Jan 17, 20241direct
Triton Therapeutics, Inc.$36.4M4506(b)Oct 23, 20251direct
AlphaTON Capital Corp$36.1M15506(b)Sep 17, 20251direct
Venatorx Pharmaceuticals, Inc.$35.0M3506(b)Jul 13, 20232direct
Apnimed, Inc.$35.0M7506(b)Dec 8, 20253direct
Cosmos Health Inc.$32.5M0506(b)Jan 5, 20232direct
Ionetix Corp / DE /$32.3M267506(b)Apr 23, 20261direct
Belhaven Biopharma Inc.$32.3M222506(b)Oct 15, 20251direct
VST BIO Corp$31.9M1506(b)Apr 24, 20262direct
Nocion Therapeutics, Inc.$31.1M13506(b)Mar 13, 20241direct
Phlow Corp.$30.5M9506(b)Feb 14, 20251direct
Vesalius Longevity Labs Inc.$30.1M62506(b)Nov 3, 20261direct
Petros Pharmaceuticals, Inc.$30.0M15506(b)Jul 21, 20231direct
Relay Therapeutics, Inc.$30.0M1506(b)Jan 10, 20241direct
NEKTAR THERAPEUTICS$30.0M1506(b)Mar 19, 20241direct
Kinaset Therapeutics, Inc.$28.5M3506(b)Jul 17, 20232direct
Spiral Therapeutics Inc$27.1M34506(b)Apr 16, 20261direct
MyMD Pharmaceuticals, Inc.$26.9M4506(b)May 31, 20241direct
Sensorium Therapeutics, Inc.$26.8M19506(b)Jul 15, 20252direct
Spectrum Antimicrobials, Inc.$26.4M247506(c)Apr 1, 20267direct
Avenacy Inc.$26.0M2506(b)Nov 26, 20241direct
858 Therapeutics, Inc.$25.2M12506(b)Jul 11, 20241direct
CNS Pharmaceuticals, Inc.$22.5M13506(b)May 19, 20261direct
AXIAL THERAPEUTICS, INC.$19.4M29506(b)Feb 11, 20251direct
Capacity Bio, Inc.$19.2M13506(b)Jan 18, 20231direct
Artax Biopharma, Inc.$19.0M30506(b)May 5, 20263direct
CytoDyn Inc.$18.6M194506(b)May 11, 20261direct
Paulex Bio Inc.$18.5M163506(c)Dec 18, 20251direct
Land Therapeutics Inc.$17.5M12506(b)Oct 21, 20262direct
TALPHERA, INC.$17.0M13506(b)Sep 15, 20251direct
Neumentum, Inc.$16.6M33506(b)Apr 28, 20233direct
EIKONOKLASTES THERAPEUTICS, INC.$16.1M15506(b)Oct 6, 20262direct
Evergreen Theragnostics Inc.$15.5M58506(b)Aug 18, 20231direct
MindImmune Therapeutics, Inc.$15.2M15506(b)Mar 5, 20262direct
RENOVION, INC.$15.0M24506(b)Mar 28, 20231direct
KIORA PHARMACEUTICALS INC$15.0M13506(b)Feb 14, 20241direct
Incyclix Bio, LLC$15.0M5506(b)Jul 6, 20232direct
Kamal Therapeutics, Inc.$13.8M41506(b)Nov 24, 20251direct
Spine BioPharma, Inc.$13.5M10506(b)Dec 18, 20241direct
Acta Pharmaceuticals, Inc.$13.4M29506(b)Apr 22, 20242direct
Groff North America, LLC$13.1M24506(b)Jul 14, 20231direct
ZETAGEN THERAPEUTICS, INC.$12.9M35506(b)Nov 12, 20252direct
Enveric Biosciences, Inc.$12.8M2506(b)Apr 19, 20232direct
resistanceBio, Inc.$12.8M44506(b)Jan 31, 20241direct
Sentonix, Inc.$12.7M17506(b)Aug 20, 20261direct

Source: SEC EDGAR Form D and D/A filings. A Form D is a notice of an exempt offering; the SEC does not review or approve the offering. Reported figures are the issuer's own. Other groups: the full directory.